Preclinical and in vitro studies use the GLOW blend to examine tissue-remodeling mechanisms, with GHK-Cu studied in relation to collagen-synthesis signaling, TB-500 in relation to cell migration and inflammatory signaling, and BPC-157 in relation to angiogenic and growth-factor pathways.